Leit í EES-gagnagrunni
Commission Implementing Decision (EU) 2024/865 of 18 March 2024 specifying the values relating to the performance of manufacturers and pools of manufacturers of new passenger cars and new light commercial vehicles for the calendar year 2022 pursuant to Regulation (EU) 2019/631 of the European Parliament and of the Council
D095068/01
Commission Implementing Decision (EU) 2024/888 of 22 March 2024 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094983/01
Commission Implementing Decision (EU) 2024/732 of 28 February 2024 postponing the expiry date of the approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094022/02
Commission Implementing Decision (EU) 2024/731 of 28 February 2024 postponing the expiry date of the approval of indoxacarb for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094984/01
Commission Implementing Decision (EU) 2024/787 of 28 February 2024 postponing the expiry date of the approval of magnesium phosphide for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094927/01
Commission Implementing Decision (EU) 2024/734 of 27 February 2024 postponing the expiry date of the approval of brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094023/02
Commission Implementing Decision (EU) 2024/733 of 28 February 2024 postponing the expiry date of the approval of cholecalciferol for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094026/02
Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/391 of 26 January 2024 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize Bt11 × MIR162 × MIR604 × MON 89034 × 5307 × GA21 and thirty sub-combinations, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/389 of 26 January 2024 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified oilseed rape Ms8, Rf3 and Ms8 × Rf3 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/388 of 26 January 2024 amending Implementing Decision (EU) 2021/1385 as regards the scope extension of the authorisation and repealing Implementing Decision (EU) 2015/701
Commission Implementing Decision (EU) 2024/237 of 15 January 2024 amending Implementing Decision (EU) 2019/450 as regards the publication of references of European Assessment Documents for three-layer polyethylene-based coating for corrosion protection of steel pipes and other construction products
D093516/01
Commission Implementing Decision (EU) 2024/222 of 12 January 2024 postponing the expiry date of the approval of boric acid for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D093517/01
Commission Implementing Decision (EU) 2024/208 of 10 January 2024 postponing the expiry date of the approval of disodium tetraborate for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D093515/01
Commission Implementing Decision (EU) 2024/241 of 15 January 2024 not approving Willaertia magna c2c maky as an active substance for use in biocidal products of product-type 11 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/2634 of 27 November 2023 concerning the extension of the action taken by the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products permitting the making available on the market and use of the biocidal product Biobor JF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/2619 of 24 November 2023 postponing the expiry date of the approval of hydrochloric acid for use in biocidal products of product-type 2 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D092102/02
Commission Implementing Decision (EU) 2023/2672 of 27 November 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product family INTEROX Biocidal Product Family 2 raised in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council
D090792/03
Commission Implementing Decision (EU) 2023/2630 of 27 November 2023 on the unresolved objections regarding the conditions for granting an authorisation for the product Procalx in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D092096/02
Commission Implementing Decision (EU) 2023/2648 of 27 November 2023 not approving silver zeolite as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D092097/02
Commission Implementing Decision (EU) 2023/2622 of 24 November 2023 not approving silver zinc zeolite as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2023/2484 of 9 November 2023 amending Implementing Decision 2012/715/EU as regards the inclusion of Taiwan in the list of third countries established by that Decision
Commission Implementing Decision (EU) 2023/2207 of 13 October 2023 amending Implementing Decision (EU) 2016/2272 on the equivalence of financial markets in Australia in accordance with Regulation (EU) No 648/2012 of the European Parliament and of the Council to take account of recent developments in the financial markets in Australia
Commission Implementing Decision (EU) 2023/2176 of 13 October 2023 amending Implementing Decision (EU) 2021/1388 as regard the reference material provider
Commission Implementing Decision (EU) 2023/2143 of 13 October 2023 renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified maize MIR162 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council and amending Commission Implementing Decisions (EU) 2016/1685, (EU) 2019/1305 and (EU) 2019/2087 as regards the reference material